Business Context and Reporting Period
Company: Broadway Financial Corporation (BYFC)
Filing Type: Form 8-K (Current Report)
Date of Report: June 2, 2022 (Event Date: June 7, 2022)
Context: The Company closed a private placement of Senior Non-Cumulative Perpetual Preferred Stock, Series C, with the United States Department of the Treasury under the Emergency Capital Investment Program.
Key Financial Metrics
- Capital Raised: $150,000,000 in cash proceeds.
- Securities Issued: 150,000 shares of Series C Preferred Stock.
- Liquidation Value: $1,000 per share.
- Dividend Rate: 0% for the first two years; thereafter, a floor of 0.50% and a ceiling of 2.00% (payable quarterly).
- Impact on Capital: The investment is expected to more than double the Company's Tier 1 Capital.
Material Changes
The primary material change is the entry into a Material Definitive Agreement and the unregistered sale of equity securities. The Company filed a Certificate of Designations with the State of Delaware to establish the rights and preferences of the new Series C Preferred Stock. This transaction significantly alters the Company's capital structure and liquidity position.
Outlook, Management Commentary, and Risks
- Use of Proceeds: Net proceeds will be used to increase access to capital for small and minority-owned businesses, not-for-profits, and affordable housing in traditionally underserved markets.
- Strategic Impact: Management states the capital injection will allow the Company to enhance the scale of operations and improve business economics.
- Redemption Terms: The Company may redeem shares on or after June 15, 2027, or within 90 days of a Regulatory Capital Treatment Event, subject to Federal banking agency approval.
- Voting Rights: Holders generally lack voting rights but possess specific veto powers regarding senior stock authorization, amendments affecting their rights, mergers, and changes in beneficial ownership exceeding 50%.
Investor Verification Checklist
- Verify the exact terms of the dividend rate calculation in the Purchase Agreement (Exhibit 10.1).
- Confirm the Company's current Tier 1 Capital levels to validate the "more than double" claim.
- Review the Certificate of Designations (Exhibit 3.1) for specific restrictions on the Company's operations.
- Monitor future filings for the shelf registration statement required under the Registration Rights Agreement.